Rare diseases
Investigational molecules
Locations
Back to Bulgaria14 clinical trials in Cherven Bryag, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Efficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia
BulgariaA study to evaluate the effectiveness and safety of DT-101 in adults with major depressive disorder
BulgariaA Study of ACP-204 Tartrate for Adults With Lewy Body Dementia Psychosis
BulgariaA Study Testing ACP-204 Tartrate Compared to Placebo for Adults with Lewy Body Dementia Psychosis
BulgariaStudy on ITI-1284 for Treating Psychosis in Alzheimer's Patients
BulgariaStudy on Lumateperone for Patients with Major Depressive Disorder Not Responding to Antidepressants
BulgariaLong-Term Safety Study of ACP-204 for Adults with Alzheimer's Disease Psychosis
BulgariaLong-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms
BulgariaStudy on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder
BulgariaStudy of ACP-204 for Treating Psychosis in Adults with Alzheimer's Disease
BulgariaStudy of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms
BulgariaBulgariaThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical research focusing on major depressive disorder (MDD) evaluates novel therapeutic approaches and treatment combinations for patients with inadequate response to standard medications.
Multiple trials are exploring innovative compounds to enhance the effectiveness of existing antidepressant therapies.
Ongoing investigations into schizophrenia treatment focus on developing adjunctive therapies for patients with inadequately controlled symptoms.
Research emphasizes the evaluation of novel therapeutic combinations to improve patient outcomes.
Clinical trials examining new treatments for Alzheimer's Disease psychosis, with particular attention to managing psychiatric symptoms in affected patients.
Studies focus on both short-term efficacy and long-term safety of novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
